Altrinsic Global Advisors LLC Biogen Inc. Transaction History

Altrinsic Global Advisors LLC

$2.13 Billion
Q1 2024

A detailed history of Altrinsic Global Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Altrinsic Global Advisors LLC holds 42,039 shares of BIIB stock, worth $9.75 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

42,039

Previous 44,551 5.64%

Holding current value

$9.75 Million

Previous $11.5 Million 21.37%

% of portfolio

0.42%

Previous 0.5%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $532,594 - $672,487	-2,512 Reduced 5.64%	42,039 $9.06 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $580,959 - $699,323	-2,610 Reduced 5.53%	44,551 $11.5 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $611,466 - $690,138	-2,414 Reduced 4.87%	47,161 $12.1 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $605,825 - $700,050	-2,201 Reduced 4.25%	49,575 $14.1 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $3.19 Million - $3.64 Million	12,449 Added 31.66%	51,776 $14.4 Million

Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $484,684 - $588,902	-1,920 Reduced 4.65%	39,327 $10.9 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $5.16 Million - $7.12 Million	-26,518 Reduced 39.13%	41,247 $11 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $760,099 - $903,900	-4,053 Reduced 5.64%	67,765 $13.8 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $7.8 Million - $9.83 Million	-40,265 Reduced 35.92%	71,818 $15.1 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $3.12 Million - $4.01 Million	-13,938 Reduced 11.06%	112,083 $26.9 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $330,532 - $431,050	1,168 Added 0.94%	126,021 $35.7 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $375,809 - $601,744	-1,451 Reduced 1.15%	124,853 $43.2 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $609,075 - $713,567	-2,507 Reduced 1.95%	126,304 $35.3 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $1.44 Million - $2.17 Million	6,102 Added 4.97%	128,811 $31.5 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $1.76 Million - $2.03 Million	-6,634 Reduced 5.13%	122,709 $34.8 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $1.52 Million - $2.02 Million	5,887 Added 4.77%	129,343 $34.6 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $3.36 Million - $4.26 Million	-12,488 Reduced 9.19%	123,456 $39.1 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $3.37 Million - $4.66 Million	-15,336 Reduced 10.14%	135,944 $40.3 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $3.26 Million - $3.66 Million	14,993 Added 11.0%	151,280 $35.2 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $6.18 Million - $6.82 Million	28,202 Added 26.09%	136,287 $31.9 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $3.13 Million - $4.9 Million	14,458 Added 15.44%	108,085 $25.5 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $3.18 Million - $4.02 Million	11,410 Added 13.88%	93,627 $28.2 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $4.76 Million - $6.22 Million	-16,218 Reduced 16.48%	82,217 $29 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $8.32 Million - $9.91 Million	32,293 Added 48.82%	98,435 $28.6 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $6.76 Million - $9.56 Million	-25,979 Reduced 28.2%	66,142 $18.1 Million
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $7.31 Million - $8.19 Million	-23,769 Reduced 20.51%	92,121 $29.3 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $32.6 Million - $38.2 Million	115,890	115,890 $36.3 Million

Others Institutions Holding BIIB

# of Institutions

1,046

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altrinsic Global Advisors LLC with notifications on news.

Account

Altrinsic Global Advisors LLC Biogen Inc. Transaction History